A gas-chromatographic method is described for determination of codeine and norcodeine in human plasma.
concentration of norcodeine was found in the plasma by this method.
With the current interest in drug efficacy and bioavailability, a sensitive and precise method is needed for determination of codeine and its metabolites in biological fluids. Many papers have been published describing sensitive and specific gas-chromatographic methods for assaying codeine in the urine of animals (1) or man (2, 3). However, because of the properties of urine and the relatively high concentration of codeine and metabolites in this medium, these methods were of little value for measuring the drug in plasma.
In 1966, Schmerzler et al. (4) reported a gas-chromatographic method for determination of codeine in plasma and urine. We found this method difficult to reproduce with the accuracy and precision necessary for bioavailability studies involving therapeutic doses of codeine sulfate. Procedures have been developed for analysis of various drugs, including codeine, in biological fluids by use of gas chromatography (5-7) and combined gas-and thin-layer chromatography (8) .
Although these methods appear sensitive and specific, they are more suited for forensic toxicology than for bioavailability studies.
A gaschromatographic/mass-spectrometric method for assaying codeine in plasma and urine was developed by Ebbighausen et al. (9) .
Materials and Methods

Apparatus
60
.60
.
42
20
.00
30
22
.10
NG/tlL Figure 2 shows plots obtained in this manner from the mean peak ratios for four calibration curves, and Table 2 shows the variability of these four curves. Each calibration curve was prepared on a different day. Fig. 3 . MaSS spectra of (A) codeine in extract of plasma subject 2, 1 h after dose and (B) codeine, norcodeine carbamate, and papaverine In extract from normal plasma to which drugs were added sive bleed from an OV-225 column, which adversely affects the quality of the mass spectrum, we used an OV-17 packing in the mass-spectrometric analysis. Figure 3 shows the fragmentation patterns for codeine extracted from subject's plasma and for codeine, norcodeine carbamate, and papaverine from plasma supplemented with drugs.
Results
Mass Spectrometry
Analytical Variables
Accuracy and precision.
To determine the precision and accuracy of the assay, we prepared 3-mi plasma samples containing known concentrations of 
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